CUV 1.60% $14.74 clinuvel pharmaceuticals limited

epitan makes me go peepee, page-12

  1. 680 Posts.
    re: annual meeting tomorrow-buyers could be coming Nonsense, this stock is overpriced, its become a daytreder plaything.
    6 months ago there would be less than 200k shares traded daily.
    Now we are seeing millions and very large price swings.
    As I said before nothing much has changed except for the trials.
    They don't even have a delivery method.
    FDA approval is a long way ahead
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.